Chaihushugan Decoction and Wen Dan Tang for Insomnia

Overview

This study aims to evaluate the clinical effectiveness of Traditional Chinese Medicine (TCM) in treating sleep disorders, specifically chronic insomnia. While conventional TCM treatments often rely heavily on subjective patient feedback, this clinical trial incorporates objective diagnostic tools, including Digital Polysomnography (PSG) and actigraphy, to gather data-driven sleep quality metrics. Participants will be randomly assigned to receive either Chaihushugan Decoction or Wen Dan Tang for an 8-week treatment period. Subjective improvements will be tracked using standardized clinical questionnaires such as the Insomnia Severity Index (ISI) and Pittsburgh Sleep Quality Index (PSQI). The findings from this trial will help clarify the scientific basis and treatment pathways of these two classic herbal formulations for sleep management.

This pilot randomized, parallel, head-to-head clinical trial is designed to investigate and compare the therapeutic effects of two classic Traditional Chinese Medicine (TCM) herbal formulas, Chaihushugan Decoction and Wen Dan Tang, for patients suffering from chronic insomnia. Eligible patients recruited from the outpatient clinic of Tainan Hospital will be randomly allocated to one of the two intervention arms in a 1:1 ratio. Group A will receive Chaihushugan Decoction (2g, three times a day, oral administration), and Group B will receive Wen Dan Tang (2g, three times a day, oral administration). The total intervention period for both groups is 8 weeks. To overcome the limitations of relying solely on subjective patient self-reports, this study implements a rigorous combination of objective and subjective assessment protocols. Objective sleep parameters-including sleep efficiency, total sleep time, sleep architecture, arousal index, and apnea-hypopnea index (AHI)-will be measured using overnight Digital Polysomnography (PSG) and actigraphy tracking. These evaluations will be conducted at three time points: baseline, week 4 (mid-treatment), and week 8 (post-treatment). Simultaneously, standardized subjective clinical questionnaires will be administered to monitor psychological and sleep quality changes, including the Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and the Hospital Anxiety and Depression Scale (HADS). The primary objective is to evaluate data-driven clinical responses and physiological alterations associated with these two distinct TCM patterns in sleep management.